{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:25:49Z","timestamp":1648517149572},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1007\/s11892-003-0043-8","type":"journal-article","created":{"date-parts":[[2007,5,22]],"date-time":"2007-05-22T23:34:51Z","timestamp":1179876891000},"page":"1-3","source":"Crossref","is-referenced-by-count":0,"title":["Medical management of obesity: A clinical imperative?"],"prefix":"10.1007","volume":"3","author":[{"given":"William G.","family":"Haynes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"43_CR1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.282.16.1519","volume":"282","author":"AH Mokdad","year":"1999","unstructured":"Mokdad AH, Serdula MK, Dietz WH, et al.: The spread of the obesity epidemic in the United States, 1991\u20131998. JAMA 1999, 282:1519\u20131522.","journal-title":"JAMA"},{"key":"43_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199509143331101","volume":"333","author":"JE Manson","year":"1995","unstructured":"Manson JE, Willett WC, Stampfer MJ, et al.: Body weight and mortality among women. N Engl J Med 1995, 333:677\u2013685.","journal-title":"N Engl J Med"},{"key":"43_CR3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00024","volume":"119","author":"SN Blair","year":"1993","unstructured":"Blair SN, Shaten J, Brownell K, et al.: Body weight change, allcause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med 1993, 119:749\u2013775.","journal-title":"Ann Intern Med"},{"key":"43_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","volume":"352","author":"L Sj\u00f6str\u00f6m","year":"1998","unstructured":"Sj\u00f6str\u00f6m L, Rissanen A, Andersen T, et al.: Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998, 352:167\u2013172.","journal-title":"Lancet"},{"key":"43_CR5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archinte.160.9.1321","volume":"160","author":"SB Heymsfield","year":"2000","unstructured":"Heymsfield SB, Segal KR, Hauptman J, et al.: Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000, 160:1321\u20131326.","journal-title":"Arch Intern Med"},{"key":"43_CR6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/diacare.21.8.1288","volume":"21","author":"PA Hollander","year":"1998","unstructured":"Hollander PA, Elbein SC, Hirsch IB, et al.: Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998, 21:1288\u20131294.","journal-title":"Diabetes Care"},{"key":"43_CR7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","volume":"286","author":"A Wirth","year":"2001","unstructured":"Wirth A, Krause J: Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001, 286:1331\u20131339.","journal-title":"JAMA"},{"key":"43_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1463-1326.2000.00081.x","volume":"2","author":"K Fujioka","year":"2000","unstructured":"Fujioka K, Seaton TB, Rowe E, et al.: Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab 2000, 2:175\u2013187.","journal-title":"Diabetes Obes Metab"},{"key":"43_CR9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.19.9.920","volume":"19","author":"A Fontbonne","year":"1996","unstructured":"Fontbonne A, Charles MA, Juhan-Vague I, et al.: The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group. Diabetes Care 1996, 19:920\u2013926.","journal-title":"Diabetes Care"},{"key":"43_CR10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1053\/meta.2001.28078","volume":"50","author":"JP Kay","year":"2001","unstructured":"Kay JP, Alemzadeh R, Langley G, et al.: Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metab Clin Exp 2001, 50:1457\u20131461.","journal-title":"Metab Clin Exp"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-003-0043-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11892-003-0043-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-003-0043-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:56:10Z","timestamp":1559433370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11892-003-0043-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s11892-003-0043-8","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}